Immunology Treatment for Biofilms
Abstract
The invention provides a composition for use in raising an immune response to P. gingivalis in a subject, the composition comprising an amount effective to raise an immune response of at least one polypeptide having an amino acid sequence substantially identical to at least 50 amino acids, or an antigenic or immunogenic portion, of one of the polypeptides corresponding to accession numbers selected from the group consisting of AAQ65462, AAQ65742, AAQ66991, AAQ65561, AAQ66831, AAQ66797, AAQ66469, AAQ66587, AAQ66654, AAQ66977, AAQ65797, AAQ65867, AAQ65868, AAQ65416, AAQ65449, AAQ66051, AAQ66377, AAQ66444, AAQ66538, AAQ67117 and AAQ67118. The invention also provides a method of preventing or treating a subject for P. gingivalis infection comprising administering to the subject a composition of the invention
Claims
exact text as granted — not AI-modified1 . A composition for use in raising an immune response to P. gingivalis in a subject, the composition comprising an amount effective to raise an immune response of at least one antigenic or immunogenic portion of a polypeptide corresponding to accession numbers selected from the group consisting of AAQ65462, AAQ65742, AAQ66991, AAQ65561, AAQ66831, AAQ66797, AAQ66469, AAQ66587, AAQ66654, AAQ66977, AAQ65797, AAQ65867, AAQ65868, AAQ65416, AAQ65449, AAQ66051, AAQ66377, AAQ66444, AAQ66538, AAQ67117 and AAQ67118.
2 . A composition of claim 1 wherein the portion has an amino acid sequence that is substantially identical to at least 50 amino acids of one of the polypeptides.
3 . A composition of claim 2 wherein the polypeptide corresponds to an accession number selected from the group consisting of AAQ65462, AAQ66991, AAQ65561 and AAQ66831.
4 . A composition of claim 2 wherein the polypeptide corresponds to accession number AAQ65742.
5 . A composition for use in raising an immune response to P. gingivalis in a subject, the composition comprising amount effective to raise an immune response of at least one polypeptide having an amino acid sequence substantially identical to at least 50 amino acids of a polypeptide expressed by P. gingivalis and that is predicted by the CELLO program to be extracellular.
6 . A composition for use in raising an immune response to P. gingivalis in a subject, the composition comprising an amount effective to raise an immune response of at least one polypeptide having an amino acid sequence selected substantially identical to at least 50 amino acids of a polypeptide that causes an immune response in a mouse or a rabbit.
7 . A method of preventing, inhibiting or treating a subject for periodontal disease comprising administering to the subject an effective amount of composition according to claim 1 .
8 . A method of preventing or treating a subject for P. gingivalis infection comprising administering to the subject a composition according to claim 1 .
9 . An antibody raised against an antigenic region of a polypeptide having an amino acid sequence, the sequence being substantially identical to at least 50 amino acids of one of the polypeptides corresponding to accession numbers AAQ65462, AAQ65742, AAQ66991, AAQ65561, AAQ66831, AAQ66797, AAQ66469, AAQ66587, AAQ66654, AAQ66977, AAQ65797, AAQ65867, AAQ65868, AAQ65416, AAQ65449, AAQ66051, AAQ66377, AAQ66444, AAQ66538, AAQ67117 and AAQ67118.
10 . An antibody of claim 9 wherein the polypeptide corresponds to an accession number selected from the group consisting of AAQ65462, AAQ66991, AAQ65561 and AAQ66831.
11 . An antibody of claim 9 wherein the polypeptide corresponds to an accession number selected from the group consisting of AAQ65742.Join the waitlist — get patent alerts
Track US2010297179A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.